Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

by Julia Moióli,FAPESPAbstract. Credit:Journal of Proteome Research(2022). DOI: 10.1021/acs.jproteome.2c00630Preclinical trials have shown that zika virus can inhibit the spread of p

Updated on: January 28,2024

Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

by Julia Moióli,FAPESPAbstract. Credit:Journal of Proteome Research(2022). DOI: 10.1021/acs.jproteome.2c00630Preclinical trials have shown that zika virus can inhibit the spread of p

Updated on:January 28,2024

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on: September 27,2024

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on:September 27,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on: February 03,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on:February 03,2024

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on: July 05,2024

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on:July 05,2024

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho

Updated on: January 30,2024

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho

Updated on:January 30,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on: January 29,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on:January 29,2024

Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

byBritish Medical JournalCredit:BMJ(2023). DOI: 10.1136/bmj-2022-074684Most women diagnosed with early stage breast cancer today can expect to become long-term cancer survivors, find

Updated on: January 22,2024

Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

byBritish Medical JournalCredit:BMJ(2023). DOI: 10.1136/bmj-2022-074684Most women diagnosed with early stage breast cancer today can expect to become long-term cancer survivors, find

Updated on:January 22,2024

Study finds females have lower salivary flow than males before and after radiation therapy for head, neck cancer

byUniversity of ConnecticutCredit: Unsplash/CC0 Public DomainReduced salivary flow, or hyposalivation, can cause an increased risk for tooth decay and other mouth conditions. Measuring salivary

Updated on: September 07,2024

Study finds females have lower salivary flow than males before and after radiation therapy for head, neck cancer

byUniversity of ConnecticutCredit: Unsplash/CC0 Public DomainReduced salivary flow, or hyposalivation, can cause an increased risk for tooth decay and other mouth conditions. Measuring salivary

Updated on:September 07,2024

Discovery may bolster chemotherapy potency while protecting the heart from side-effects

by University of Alberta Faculty of Medicine & Dentistry(From left) Researchers Gopinath Sutendra and Bruno Saleme in a lab at the University of Alberta. The two have found a new therapeutic

Updated on: April 14,2024

Discovery may bolster chemotherapy potency while protecting the heart from side-effects

by University of Alberta Faculty of Medicine & Dentistry(From left) Researchers Gopinath Sutendra and Bruno Saleme in a lab at the University of Alberta. The two have found a new therapeutic

Updated on:April 14,2024

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on: January 04,2024

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on:January 04,2024

Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

by European Organisation for Research and Treatment of CancerA patient exercising as part of the clinical trial. Credit: EORTC / Anouk HienschTaking part in an exercise program reduced pain and fatigu

Updated on: March 30,2024

Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

by European Organisation for Research and Treatment of CancerA patient exercising as part of the clinical trial. Credit: EORTC / Anouk HienschTaking part in an exercise program reduced pain and fatigu

Updated on:March 30,2024